Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study

In the UK, patients with one or two adenomas, of which at least one is ≥ 10 mm in size, or three or four small adenomas, are deemed to be at intermediate risk of colorectal cancer (CRC) and referred for surveillance colonoscopy 3 years post polypectomy. However, colonoscopy is costly, can cause disc...

Full description

Saved in:
Bibliographic Details
Published in:Health technology assessment (Winchester, England) England), 2019-01, Vol.23 (1), p.1-84
Main Authors: Atkin, Wendy, Cross, Amanda J, Kralj-Hans, Ines, MacRae, Eilidh, Piggott, Carolyn, Pearson, Sheena, Wooldrage, Kate, Brown, Jeremy, Lucas, Fiona, Prendergast, Aaron, Marchevsky, Natalie, Patel, Bhavita, Pack, Kevin, Howe, Rosemary, Skrobanski, Hanna, Kerrison, Robert, Swart, Nicholas, Snowball, Julia, Duffy, Stephen W, Morris, Stephen, von Wagner, Christian, Halloran, Stephen
Format: Article
Language:English
Subjects:
Aged
Colonoscopy - economics
Colonoscopy - methods
Colorectal Neoplasms - diagnosis
Cost-Benefit Analysis
Early Detection of Cancer - economics
Early Detection of Cancer - methods
Early Detection of Cancer - psychology
Early Detection of Cancer - standards
Female
Health Knowledge, Attitudes, Practice
Hemoglobins - analysis
Humans
Immunochemistry - economics
Immunochemistry - methods
Male
Middle Aged
Occult Blood
Patient Preference
Sensitivity and Specificity
United Kingdom
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the UK, patients with one or two adenomas, of which at least one is ≥ 10 mm in size, or three or four small adenomas, are deemed to be at intermediate risk of colorectal cancer (CRC) and referred for surveillance colonoscopy 3 years post polypectomy. However, colonoscopy is costly, can cause discomfort and carries a small risk of complications. To determine whether or not annual faecal immunochemical tests (FITs) are effective, acceptable and cost saving compared with colonoscopy surveillance for detecting CRC and advanced adenomas (AAs). Diagnostic accuracy study with health psychology assessment and economic evaluation. Participants were recruited from 30 January 2012 to 30 December 2013 within the Bowel Cancer Screening Programme in England. Men and women, aged 60-72 years, deemed to be at intermediate risk of CRC following adenoma removal after a positive guaiac faecal occult blood test were invited to participate. Invitees who consented and returned an analysable FIT were included. We offered participants quantitative FITs at 1, 2 and 3 years post polypectomy. Participants testing positive with any FIT were referred for colonoscopy and not offered further FITs. Participants testing negative were offered colonoscopy at 3 years post polypectomy. Acceptibility of FIT was assessed using discussion groups, questionnaires and interviews. The primary outcome was 3-year sensitivity of an annual FIT versus colonoscopy at 3 years for detecting advanced colorectal neoplasia (ACN) (CRC and/or AA). Secondary outcomes included participants' surveillance preferences, and the incremental costs and cost-effectiveness of FIT versus colonoscopy surveillance. Of 8008 invitees, 5946 (74.3%) consented and returned a round 1 FIT. FIT uptake in rounds 2 and 3 was 97.2% and 96.9%, respectively. With a threshold of 40 µg of haemoglobin (Hb)/g faeces (hereafter referred to as µg/g), positivity was 5.8% in round 1, declining to 4.1% in round 3. Over three rounds, 69.2% (18/26) of participants with CRC, 34.3% (152/443) with AAs and 35.6% (165/463) with ACN tested positive at 40 µg/g. Sensitivity for CRC and AAs increased, whereas specificity decreased, with lower thresholds and multiple rounds. At 40 µg/g, sensitivity and specificity of the first FIT for CRC were 30.8% and 93.9%, respectively. The programme sensitivity and specificity of three rounds at 10 µg/g were 84.6% and 70.8%, respectively. Participants' preferred surveillance strategy was 3-yearly colonoscopy plus annua
ISSN:1366-5278
2046-4924
DOI:10.3310/hta23010